MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-MH-33-0060508
Syglak Laboratories Private Limited - chemicals and materials in Badlapur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2017
₹64.04 Lakh
▼ 75% YoY
Net profit · FY 2017
₹44,739
Net margin 0.7%
EBITDA · FY 2017
₹13.62 Lakh
EBITDA margin 21.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2.7 Lakh
Issued & subscribed
Open charges
₹4.36 Cr
Secured borrowings
Company age
22 yrs
Est. 2004
Directors on board
2
As per MCA filings
About Syglak Laboratories Private Limited
Data last updated:
Syglak Laboratories Private Limited is a private limited company based in Badlapur, Maharashtra, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 03 December 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2004PTC149815. Its GSTIN is 27AAICS7768N1ZC (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.7 Lakh. It is led by directors Lav Kumar Vadehra and Gaurav Vadehra.
Its last annual general meeting (AGM) was held on 30 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at F – 14 MIDC Kulgaon Badlapur East, Maharashtra, India – 421503.
As per the financials filed for FY 2017, the company reported a revenue of ₹64.04 Lakh, a decline of 75% compared to the previous year. For the same year it recorded a net profit of ₹44,739 (net margin 0.7%) and EBITDA of ₹13.62 Lakh (EBITDA margin 21.3%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years.
As per MCA filings, the company has open charges of ₹4.36 Cr on record. Court records list 5 cases involving the company, including 5 filed against it; 1 case is pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹34 Lakh; the latest was in February 2012. Its 3 peer companies in the Chemicals industry (Formulations, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Laennec Bioscience Private Limited with revenue of ₹64.3 Lakh.
Syglak Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0060508). The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website splrc.com.
Company details
CIN U24230MH2004PTC149815
Registration Number 149815
Incorporation Date 03 December 2004
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2018
Date of Balance Sheet 31 March 2018
Compliance Status Active Non-Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0060508
Recognitions & Rankings of Syglak Laboratories
Contact details
Syglak Laboratories Private Limited's registered office is in Badlapur, Maharashtra. Its website is splrc.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressF – 14 MIDC Kulgaon Badlapur East, Maharashtra, India – 421503
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Syglak Laboratories Private Limited, buy the company report.
Comprehensive company report
Syglak Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Syglak Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Syglak Laboratories Private Limited, buy the company report.
Financials of Syglak Laboratories Private Limited
FY 2018 filings availableSyglak Laboratories Private Limited reported revenue of ₹64.04 Lakh (down 75% YoY) for FY 2017.
Revenue · FY 2017
₹64.04 Lakh ▼ 75%
Net profit · FY 2017
₹44,739 margin 0.7%
EBITDA · FY 2017
₹13.62 Lakh margin 21.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 75%
3 years · compounded
▼ 11%
EBITDA CAGR growth
1 year
▼ 27%
3 years · compounded
▼ 12%
Revenue has declined at a compounded annual rate (CAGR) of 11% over three years, including a 75% fall in the latest year. EBITDA fell 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹64.04 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹13.62 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹44,739 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 21.3% | ||
| Net Profit Margin | 0.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Syglak Laboratories Private Limited, buy the company report.
Board of directors of Syglak Laboratories Private Limited
Syglak Laboratories has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lav Kumar Vadehra | Director | 14 Feb 2014 | 12 Years 8 Months | Current |
| Gaurav Vadehra Also directs: Glazers Exports (India) Pvt Ltd | Director | 21 Jul 2015 | 11 Years 3 Months | Current |
Peer comparison
Syglak Laboratories Private Limited is compared with the 3 companies closest to it by revenue in the Chemicals industry (Formulations, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Laennec Bioscience Private Limited | ₹64.3 Lakh (FY 2024) | 153.0% | Tamil Nadu, India | |||
| Syglak Laboratories Private Limitedthis company | ₹64.04 Lakh (FY 2017) | ₹44,739 | 0.7% | -75.0% | Badlapur, Maharashtra, India | |
| Faveo Life Sciences Private Limited | ₹63.94 Lakh (FY 2025) | 4.0% | Hyderabad, Telangana, India | |||
| Vidi Laboratries Private Limited | ₹63.93 Lakh (FY 2025) | 10.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Syglak Laboratories Private Limited, buy the company report.
Shareholding
The shareholding of Syglak Laboratories Private Limited is on record for 4 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Syglak Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.36 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Feb 2018 | 100157567 | Others | ₹2.86 Cr | Open | |
| 11 Feb 2013 | 10412095 | Syndicate Bank | ₹1.9 Lakh | Open | |
| 11 Feb 2013 | 10412108 | Syndicate Bank | ₹8 Lakh | Open | |
| 02 Mar 2012 | 10344797 | Syndicate Bank | ₹85 Lakh | Open | |
| 16 Jan 2010 | 10265853 | Syndicate Bank | ₹55 Lakh | Open |
To see the full charge records of Syglak Laboratories Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Syglak Laboratories Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹34 Lakh; the latest was in February 2012.
Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹34 Lakh
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2012 | Funding round | ₹34 Lakh | Investors: 3 individuals |
| Feb 2008 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Syglak Laboratories Private Limited has 5 court cases on record: 5 filed against it. 1 case is pending and 4 are disposed.
Total cases
5
Filed against the company
5
Pending
1
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 5 | 1 |
Cases on record (4 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU RURAL, Karnataka | Court case (Com.O.S.) | Filed against the company by Bioartha Labs Pvt. Ltd. | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Cases SS) | Filed against the company by Samarth Pharma Private Ltd | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed against the company by Indosol Exports | Pending |
| District court, Thane, Maharashtra | Criminal miscellaneous application | Filed against the company by Canara Bank | Disposed |
To see the full case history of Syglak Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Syglak Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Syglak Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICS7768N1ZC | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Syglak Laboratories Private Limited, buy the company report.
Recent activity
Syglak Laboratories Private Limited has 10 board changes on record since 2004: 6 appointments and 4 cessations. The latest: Kishore Bhooraram Choudhary ceased to be Director on 23 Aug 2016.
AGM
Syglak Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records.
Charges
A charge with Syndicate Bank of Rs. 85.00 Lakh registered on 02 Mar 2012 with Charge ID 10344797 was modified on 28 Sep 2018.
Filing
Syglak Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai Ii.
Charges
A charge with Others amounted to Rs. 286.00 Lakh with Charge ID 100157567 was registered on 06 Feb 2018.
Ceased
Kishore Bhooraram Choudhary ceased to be Director.
Appointed
Gaurav Vadehra was appointed as Director.
Ceased
Vishnu Shankar Gurav ceased to be Director.
Appointed
Kishore Bhooraram Choudhary was appointed as Director.
Appointed
Lav Kumar Vadehra was appointed as Director.
Charges
A charge with Syndicate Bank of Rs. 55.00 Lakh registered on 16 Jan 2010 with Charge ID 10265853 was modified on 16 Dec 2013.
Charges
A charge with Syndicate Bank amounted to Rs. 1.90 Lakh with Charge ID 10412095 was registered on 11 Feb 2013.
Charges
A charge with Syndicate Bank amounted to Rs. 8.00 Lakh with Charge ID 10412108 was registered on 11 Feb 2013.
8 earlier events are in the company report.
Frequently asked questions
Syglak Laboratories is an active private limited company based in Badlapur, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 03 December 2004 (22+ years old) and is registered under CIN U24230MH2004PTC149815.
Syglak Laboratories has 2 current directors:
- Lav Kumar Vadehra - Director
- Gaurav Vadehra - Director
The latest financial statements of Syglak Laboratories on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 30 September 2018. Year-wise statements from 2015 are in the company report.
The GSTIN of Syglak Laboratories is 27AAICS7768N1ZC, registered in Maharashtra.
The CIN (Corporate Identification Number) of Syglak Laboratories is U24230MH2004PTC149815. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Syglak Laboratories has 5 court cases on record: 5 filed against it. 1 is pending.
Syglak Laboratories was incorporated on 03 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
Syglak Laboratories has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹34 Lakh; the latest was in February 2012.
The peers of Syglak Laboratories by revenue are Laennec Bioscience Private Limited, Faveo Life Sciences Private Limited, Vidi Laboratries Private Limited, all in the Chemicals industry (Formulations, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kishore Bhooraram Choudhary ceased to be Director on 23 Aug 2016. Gaurav Vadehra was appointed as Director on 21 Jul 2015. Vishnu Shankar Gurav ceased to be Director on 30 Jun 2015. Syglak Laboratories has 10 board changes on record in total.
Yes, Syglak Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0060508).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages